Floatz logo

CARVEDILOL

Variceal Hemorrhage

West China HospitalSmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Variceal Hemorrhage cohort.

Asset / SponsorPhaseRating
PROPRANOLOL
West China Hospital
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
King George's Medical University
Phase 4BB
NADOLOL
National Science and Technology Council, Taiwan
Phase 4BB
PHYTONADIONE, (E)-(±)-
Tanta University
Phase 4BB
Midodrine
Hospital Clinic of Barcelona
Phase 4BB

View all 15 →

Same molecule, other indications

CARVEDILOL is also rated in:

portal hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
73 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →